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CASE REPORT
MOLECULAR IDENTIFICATION OF Bartonella henselae IN A SERONEGATIVE CAT SCRATCH 
DISEASE PATIENT WITH AIDS IN RIO DE JANEIRO, BRAZIL
Alexsandra R.M. FAVACHO(1), Isabelle ROGER(2), Amanda K. AKEMI(3), Adonai A. PESSOA JR.(1), Andrea G. VARON(2), Raphael GOMES(1),  
Daniela T. GODOY(1), Sandro PEREIRA(3) & Elba R.S. LEMOS(1)
SUMMARY
Bartonella henselae is associated with a wide spectrum of clinical manifestations, including cat scratch disease, endocarditis and 
meningoencephalitis, in immunocompetent and immunocompromised patients. We report the first molecularly confirmed case of B. 
henselae infection in an AIDS patient in state of Rio de Janeiro, Brazil. Although DNA sequence of B. henselae has been detected by 
polymerase chain reaction in a lymph node biopsy, acute and convalescent sera were nonreactive.
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INTRODUCTION
Bartonella species are small, fastidious, Gram-negative, rod-shaped 
bacteria that are associated with infections in immunocompetent 
and immunocompromised patients. There are more than 22 species 
so far described in the Bartonella genus, with Bartonella henselae, 
B. bacilliformis, and B. quintana accounting for the majority of 
human cases. Bartonella henselae, the main agent of the cat scratch 
disease (CSD), is also associated with a wide variability in clinical 
manifestations, including Parinaud’s oculoglandular syndrome, 
endocarditis, meningoencephalitis, disseminated disease, and fever of 
unknown origin2,9. Immunocompromised hosts, particularly severely 
immunocompromised patients infected with HIV, are more susceptible 
to infection from B. henselae, and the clinical course may be more 
severe9. The transmission of B. henselae from cats to humans frequently 
occurs through direct or indirect scratches, bites, or licks from infected 
cats and probably from the bite of an arthropod vector, Ctenocephalides 
felis, the cat flea2.
We report the diagnosis of B. henselae infection using molecular 
methods in an HIV-positive patient who was negative to the gold standard 
serologic tests.
CASE REPORT
A 34-year-old man infected with human immunodeficiency virus 
(HIV) from the Municipality of Rio de Janeiro, Brazil, was admitted to 
hospital in August 2011. Upon arrival, the patient was uncomfortable 
and febrile (39.5 °C) with a cluster of warm, red, enlarged, tender 
unilateral lymph nodes on the right epitrochanteric (> 10 cm), axillar, 
supraclavicular, periauricular, and posterior cervical chain (Fig. 1). 
A discrete nonpruritic rash was noted on the torso and abdomen. The 
patient had been scratched on the abdomen and bitten on the thumb by 
his 7-month-old kitten seven days before. He also mentioned numerous 
fleabites prior to the start of his symptoms and that his kitten spent most 
of the time outdoors in contact with roaming cats.
Diagnosis of HIV seropositivity had been made two years previously. 
The CD4 count was 244 cells/mm3 with a viral load of 215,857 copies/
mm3 at admission. Other laboratory data revealed biochemical panel 
and blood count within the normal range, elevated C-reactive protein, 
cultures from tissue biopsy and multiple blood cultures were sterile for 
aerobic and anaerobic bacteria, mycobacteria and fungi. The patient 
was positive for toxoplasmosis (IgG), but the serology studies for viral 
hepatitis, cytomegalovirus, and syphilis were negative.
CSD was suspected, but serum samples collected on days 11 and 19 
of the illness were nonreactive to B. henselae, using a commercial kit of 
indirect immunofluorescence assay (IFA) for class-specific IgG antibody 
(Bion®, USA). In addition, the serum from the patient’s cat was submitted 
for IFA and was B. henselae reactive (titer of 64). Histopathological 
examination of the posterior cervical node revealed a granulomatous 
inflammation and neutrophilic microabscesses. No organisms were 
observed using Gram, Ziehl-Neelson, and Warthin-Starry silver stains. 
FAVACHO, A.R.M.; ROGER, I.; AKEMI, A.K.; PESSOA Jr., A.A.; VARON, A.G.; GOMES, R.; GODOY, D.T.; PEREIRA, S. & LEMOS, E.R.S. - Molecular identification of Bartonella 
henselae in a seronegative cat scratch disease patient with AIDS in Rio de Janeiro, Brazil. Rev. Inst. Med. Trop. Sao Paulo, 56(4): 363-5, 2014.
364
Abdominal ultrasound revealed a slightly enlarged spleen; the chest 
radiograph and transthoracic echocardiography were otherwise normal.
Several days later, the patient maintained moderate fever associated 
with an episodic dull abdominal pain and worsening of the epitrochanteric 
lesion. Abdominal ultrasound and computed tomography of the abdomen 
on day 19 of the illness revealed an enlarged spleen with multiple discrete 
nodules and intra-abdominal lymphadenopathy. A lymph node ultrasound 
detected a large nonhomogeneous subcutaneous collection on the anterior 
epitrochlear region that was collected prior to antibiotic therapy and 
evaluated using culture and molecular analysis.
Intravenous amoxicillin-clavulanate (1 g) and oral azithromycin (500 
mg) were started empirically to cover bacterial infections associated 
with a cat bite and were stopped after eight days. Trimethoprim-
sulfamethoxazole 160/800 mg and HAART (tenofovir 300 mg, 
lamivudine 300 mg, and efavirenz 600 mg) were subsequently initiated 
on the 20th day of hospital stay with a progressive and steady rise in 
CD4 cell count.
DNA isolated from patient and cat serum and lymph node tissue/
aspirates patient samples were used as templates for the polymerase 
chain reaction (PCR) assays using genus-specific primers targeting the 
16S-23S rRNA intergenic region6, riboflavin synthase C gene4, the citrate 
synthase gene (gltA)7, and β subunit of RNA polymerase gene (rpoB)8. A 
second step was performed using species-specific primers targeting the 
heat shock protein gene (hrtA)1 following reported protocols.
B. henselae DNA sequences were only detected on the histological 
(lymph node tissue) sample, while the detection in cat serum samples 
was not confirmed. The amplification products were purified, and the 
sequencing was performed using an ABI PRISM BigDye terminator v.3.1 
cycle sequencing kit (Applied Biosystems, CA, USA). The resulting 
sequences (GenBank accession no. JX028199.1) were submitted to 
BLASTn, and the nucleotide sequence generated from the lymph node 
sample clearly demonstrated 100% identity with the homologous gene 
fragment of the hrtA gene from B. henselae Houston-1 strain, complete 
genome. The diagnosis of B. henselae lymphadenitis and splenitis 
was confirmed; the patient’s condition improved with the treatment, 
and he was discharged after 31 days of hospitalization. Azithromycin 
was maintained for two months. The patient remained asymptomatic 
and without evidence of recurrence of disease one year after hospital 
discharge.
DISCUSSION
Bartonella spp. have worldwide distribution and are zoonotic 
agents of public health with importance in both human and veterinary 
medicine2,5. Although bartonellosis are not notifiable diseases in Brazil, 
the number of cases has been rising in the last two decades (National 
Rickettsial Reference Laboratory 2012, unpublished data).
This study presents the first report of molecular identification of 
B. henselae in lymph node tissue specimen from a patient who is HIV 
positive and seronegative to Bartonella infection in Rio de Janeiro, 
Brazil. Although IFA assay is considered the gold standard technique for 
the diagnosis Bartonella, this patient failed to develop normal antibody 
response to this agent. Serologic sensibility varies from one laboratory to 
another ranging from nearly 100% to < 30%, depending on the antigen 
used, the cut-off chosen, and the test procedures. In addition, serological 
assays exhibit low specificity and cross-reactivity can occur between 
Bartonella spp. and agents such as Epstein-Barr virus, cytomegalovirus, 
Toxoplasma gondii and Streptococcus pyogenes10. Therefore, the 
detection of B. henselae DNA by PCR and nucleotide sequencing in the 
lymph node specimen proved to be useful in the diagnosis of infection.
The possibility that the patient’s cat might have been involved in 
zoonotic transmission was reinforced; the patient’s cat was seroreactive 
to B. henselae antigens. As cats may have persistent and asymptomatic 
bacteremia, they represent a potential danger of exposure for people with 
immunosuppressive conditions5.
The suspicion of CSD and the appropriate empiric antibiotic 
treatment, even before the molecular diagnostics, improved the clinical 
status of the patient. Although no follow-up PCR was performed, the 
patient remained entirely asymptomatic 14 months after the illness. There 
are no controlled trials of treatment for bartonellosis in HIV-infected 
individuals, but antibiotic treatment for at least three months has been 
Fig. 1 - (A) Photograph of the right epitrochlear regions showing a diffuse erythematous skin rash. (B) Total recovery from lymph node lesions after antibiotic treatment (azithromycin). 
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recommended3. In conclusion, given the low sensitivity of the serological 
assays, PCR diagnosis for B. henselae should be considered for patients 
with suspected CSD even after a negative result in serology test. This 
way, more frequent and appropriate diagnosis will be made, leading to 
a better treatment and cure.
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RESUMO
Identificação molecular de Bartonella henselae em paciente com 
SIDA soronegativo para doença da arranhadura do gato no Rio de 
Janeiro, Brasil
Bartonella henselae está associada a um amplo espectro de 
manifestações clínicas, incluindo a doença da arranhadura de gato, 
endocardite, e meningoencefalite, em pacientes imunocompetentes 
e imunocomprometidos. Relatamos o primeiro caso confirmado por 
método molecular de B. henselae em um paciente com SIDA no estado 
do Rio de Janeiro, Brasil. Apesar da sequência de DNA de B. henselae 
ser detectada pela reação em cadeia da polimerase em uma biópsia do 
linfonodo, soros das fases aguda e convalescente foram não reativos.
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